News and Community

Ai Drug Discovery, Brain-penetrant Therapy, Healthcare Technology, Iam217, Iambic, Kif18a Inhibitor, Solid Tumors, Triple-negative Breast Cancer

October 6, 2026

Iambic Announces IND Submission for IAM217, a Potentially Brain-Penetrant KIF18A Inhibitor and Second AI-Discovered Candidate

Ai Drug Discovery, Arct-2601, Arct-810, Arcturus Therapeutics, Gene Therapy, Healthcare Technology, Liver Therapeutics, Lunar 2.0, Mrna Delivery Platform, Mrna Drug Development, Mrna Therapeutics, Otc Deficiency, Rare Disease, Rna Medicine

September 24, 2026

Arcturus Therapeutics Reports Interim Phase 2 OTC Deficiency Results and Unveils Next-Generation LUNAR 2.0™ mRNA Delivery Platform

Ai Drug Discovery, Biomedical Ai, Clinical Development, Drug Development, Drug Discovery Platform, Healthcare Technology, Iambic, Machine Learning, Molecular Ai, Molecular Superintelligence, Multimodal Ai, Pharmaceutical Ai, Preclinical Research

September 22, 2026

Iambic Unveils Enchant v3, a Molecular Superintelligence Platform Built to Power End-to-End Drug Discovery and Development

Ai Drug Discovery, Antibody Discovery, Antibody Sequencing, Biotech Ai, Biotech Innovation, Drug Discovery Platform, Eli Lilly, Healthcare Technology, Lilly Tunelab, Pharmaceutical Ai, Twist Bioscience, Wet Lab Data

September 17, 2026

Twist Bioscience Partners with Lilly TuneLab to Advance Antibody Drug Discovery

Agentic Ai, Ai Drug Discovery, Biomarker Discovery, Cancer Research, Clinical Trial Design, Drug Development, Healthcare Technology, K Pro, Multimodal Data, Oncology Ai, Owkin, Pharmaceutical Ai, Precision Medicine

September 14, 2026

Owkin Licenses K Pro and Multimodal Data to Servier for Oncology Research

Ai Drug Discovery, Clinical Development, Cms, Healthcare Technology, Insilico, Mechanism Of Action

July 13, 2026

Strengthening Partnership in AI-Powered R&D Acceleration: Insilico Medicine and CMS Reveal Further Alliances in CNS Diseases

Agentic Ai Platform, Ai Drug Discovery, Multimodal Data, Oncology Drug Development, Tempus

June 1, 2026

Tempus Expands Agentic AI Platform to Speed Oncology Drug Research